NCT04304430View on ClinicalTrials.gov

Comparative Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors

CompletedOBSERVATIONAL
Enrollment

11,206

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

December 26, 2019

Study Completion Date

February 29, 2020

Conditions
Type 2 Diabetes
Interventions
DRUG

Dapagliflozin

Initiation of dapagliflozin according to clinical indication

DRUG

DPP-4 inhibitor

Initiation of DPP-4i according to clinical indication

Trial Locations (1)

35128

University Hospital of Padova, Padua

All Listed Sponsors
lead

University of Padova

OTHER

NCT04304430 - Comparative Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors | Biotech Hunter | Biotech Hunter